Long-term Tolerability and Efficacy of Adjunctive Brivaracetam in Pediatric Patients with Primary Generalized Seizures: Subgroup Analysis of an Open-label, Follow-up Trial (P8-9.009)
Authors
Sami Elmoufti
Brian D. Moseley (ORCID: https://orcid.org/0000-0001-8573-7340)
Long-term Tolerability and Efficacy of Adjunctive Brivaracetam in Pediatric Patients with Primary Generalized Seizures: Subgroup Analysis of an Open-label, Follow-up Trial (P8-9.009)
Sami Elmoufti, Brian D. Moseley, Dimitrios Bourikas, Jan‐Peer Elshoff et al.
Citations
1 citations
Journal
Neurology
Topics
Epilepsy research and treatment
Field-Weighted Citation Impact (FWCI)
1.47
article
Long-term Tolerability and Efficacy of Adjunctive Brivaracetam in Pediatric Patients with Primary Generalized Seizures: Subgroup Analysis of an Open-label, Follow-up Trial (P8-9.009)
Sami Elmoufti, Brian D. Moseley, Dimitrios Bourikas, Jan‐Peer Elshoff, Christine de la Loge, Lieven G. Lagae, Kristy Pucylowski
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Long-term Tolerability and Efficacy of Adjunctive Brivaracetam in Pediatric Patients with Primary Generalized Seizures: Subgroup Analysis of an Open-label, Follow-up Trial (P8-9.009) — Sami Elmoufti, Brian D. Moseley, et al. · Neurology (2025) | TGRS Research Map | TGRS